Upgrade to SI Premium - Free Trial

Regeneron Pharma (REGN) PT Lowered to $1,185 at RBC Capital

May 3, 2024 6:46 AM
RBC Capital analyst Brian Abrahams lowered the price target on Regeneron Pharma (NASDAQ: REGN) to $1,185.00 (from $1,189.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles